CS
ASMB icon

Candriam SCA’s Assembly Biosciences ASMB Stock Holding History

Candriam SCA’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-153,185
Closed -$4.28M – 811
2021
Q4 		$4.28M Buy
153,185
+30,781
+25% +$1.01M 0.03% 385
2021
Q3 		$5.11M Buy
122,404
+29,591
+32% +$1.24M 0.03% 395
2021
Q2 		$4.32M Sell
92,813
-1,899
-2% -$94.1K 0.03% 436
2021
Q1 		$6.61M Hold
94,712
– – 0.06% 326
2020
Q4 		$6.88M Buy
94,712
+57,212
+153% +$6.71M 0.05% 334
2020
Q3 		$7.4M Buy
+37,500
New +$9.44M 0.07% 282

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Candriam SCA's ASMB Position: Q1 2022 in Review

Candriam SCA sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 153,185 shares — an estimated $4.28M sold.

Candriam SCA first reported a position in ASMB in Q3 2020 and held it in 6 quarters. The position peaked at $7.4M in Q3 2020. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • Candriam SCA reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • Candriam SCA sold 153,185 Assembly Biosciences shares in Q1 2022, an estimated $4.28M.
  • Candriam SCA first reported a position in Assembly Biosciences in Q3 2020 and held it in 6 quarters.
  • Candriam SCA's Assembly Biosciences position peaked at $7.4M in Q3 2020.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.